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Two experimental approaches have been used to investigate possible interactions of methimazole with 
hydroxyi (OH’) and iodine (Ii-) free radicals. Meth~m~oie protects sensitive enzymes against inactivation 
caused by OH’ and I;-. Pulse radiolysis reveals the presence of transient absorbing species formed as a 
result of the direct interaction between methimazole and these free radicals. Measurements of the absolute 
rate constants indicate that these reactions proceed very rapidly at very low drug concentrations. These ex- 
periments provide direct evidence that methimazote is a potent scavenger of OH’ and I;- and they provide 
a possible explanation for the previously observed effects of this drug. 
Thyroid Free radical Iodine Antithyroid drug 
1. INTRODUCTION 2. METHODS 
Methimazole (MMI), the active metabolite of 
carbimazole, inhibits thyroid hormone biosyn- 
thesis by preventing the organification of iodide in 
the thyroid [l]. In addition to its antithyroid 
effect, there is considerable evidence that MM1 
also acts as an immunosuppressive agent in Graves’ 
disease [2,3]. It has been suggested that MM1 
supresses the immune response by inhibiting the 
function of the accessory cells in the thyroid [4]. 
Biochemical events involving free radicals may be 
important in thyroid hormone biosynthesis [5] and 
also for macrophage/monocyte function 161. MM1 
has been shown to reduce luminol-dependent 
chemiluminescence in antigen primed monocytes 
and it was suggested that MM1 may inhibit the for- 
mation of oxygen radicals 171. To explain the 
nature of the action of MM1 on the thyroid, these 
studies were designed to demonstrate whether or 
not the drug acted as a scavenger of oxygen and 
iodine free radicals. 
2.1. Enzyme inuctivation studies 
Steady-state irradiations of enzyme solutions 
were performed using the Brunel University 
60cobalt source, calibrated using standard Fricke 
dosimetry. Enzyme solutions with or without 
methimazole (Sigma) were prepared immediately 
before, and assayed immediately after irradiation. 
Lysozyme activity was assayed by measuring the 
change in turbidity of a suspension of lyophilised 
Micrococcus lysodeikticus at 450 nm [g]. The ac- 
tivity of yeast alcohol dehydrogenase (yADH) was 
assayed by measuring the formation of NADH at 
340 nm in a substrate solution containing NAD” 
PI. 
Pulse radiolysis studies were carried out using 
the Brunel 4 MeV linear accelerator as in [lo, 111. 
Briefly, solutions containing MM1 were exposed to 
a single pulse of ionising radiation (1 krad as deter- 
mined by thiocyanate dosimetry) and the products 
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of the reactions of the radicals thus formed ob- 
served directly by fast detection spectroscopy. 
2.3. Reactions 
Irradiation of aqueous solutions yields hydroxyl 
radicals (OH ’ ): 
Hz0 - OH ' + e&.) + H+ 
When solutions are saturated with N20 the yield 
of OH * is doubled: 
N20 + e(,,.) 
Hz0 , OH- + N2 + OH. 
In the presence of excess iodide ions (I-), iodine 
radicals (Ii-) are formed: 
OH. + I- - I* + OH- 
I- + I’ - Ii- 
When aqueous solutions containing formate are 
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saturated with N20/02, OH’ are scavenged by 
formate ions and superoxide radicals (Oi -) are 
formed upon reaction with 02: 
Fig. 1. Effect of OH * on the activity of a 50,ug/ml solu- 
tion of lysozyme (0) and a similar solution containing 
l0-4 MM1 (A). 
OH* + HCOO- - COO’- + Hz0 
COO’- + 02 - oi- -i- co2 
The interactions of MM1 with OH., Ii - and 
Oi - were thus studied. 
3. RESULTS 
3.1. Rote&ion of radical sensitive nzymes 
by MUZ 
Hydroxyl radicals inactivate lysozyme in a dose- 
dependent manner. Addition of MM1 (10e4 M) 
completely protects the enzyme against inactiva- 
tion at all radiation doses studied (frg.1). Iodine 
radicals inactivate yADH in a dose-dependent 
manner. Addition of MM1 (lo-’ M) protects 6Oqo 
of the original enzyme activity at 0.4 krad, at 
which dose the enzyme is compIetely inactivated in 
the absence of the drug (fig.2). 
0‘3 0.4 
DOSE(Krads) 
3.2. Direct interaction of OW and I2 * with MMZ 
Pulse radiolysis studies of NzO-saturated solu- 
tions containing 10e4 M MM1 revealed transient 
Fig.2. Effect of Ii - on the activity of a lOO~g/ml solu- 
tion of yeast alcohol dehydrogenase (A) and a similar 
absorption spectra with three absorption maxima solution containing 1O-5 M MM1 (0). 
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Fig.3. Absorption spectra of transients from the reac- 
tions of MM1 (10e4 M) with OH’ determined by pulse 
radiolysis of NjO-saturated solutions. Spectra (nor- 
malised to a radiation dose of 1 krad) were recorded at 
5 PCS after pulse in the absence (0) and presence (0) of 
10e2 M sodium formate. Inset: trace of absorption as a 
function of time at 510 nm. 
(fig.3). These represent he products of the reac- 
tion of OH- with MM1 since the parent compound 
has no absorption in this region (Amax = 250 nm) 
and addition of low3 M formate, which scavenges 
OH * , reduced the extinction of all three maxima 
by > 80%. The absolute rate constant (K) for the 
reaction of OH * and MM1 was measured using a 
competition technique [lo] and was found to be 
1.36 x 10” M-t- s-l. Transient absorption spec- 
tra of similar solutions containing 10T2 M KI 
revealed three absorption maxima (fig.4). The 
maximum at 360 nm is due to the iodine radical 
(Ii -), the product of the primary reaction of OH * 
with the iodine ions present in excess in solution. 
The maxima at 280 nm and 5 10 nm are similar to 
those observed for the reaction of OH * and MM1 
in the previous spectrum, but they appear con- 
siderably later after pulse. This indicates that they 
correspond to the products of the reaction of Ii - 
and MMI. The absolute rate constant for the reac- 
tion of MM1 and Ii - was measured directly and 
found to be 2.04 x lo9 M-i as-r. 
No transient absorption spectra were observed 
when N20/02-saturated solutions containing MM1 
and formate were irradiated providing no evidence 
for a reaction between Oi - and MMI. 
Fig.4. Absorption spectra of transients from the reac- 
tions of MM1 (10e4 M) with Ij - determined by pulse 
radiolysis of NjO-saturated solutions. Spectra (nor- 
malised to a radiation dose of 1 krad) were recorded at 
3 ,us (0) and 80 PCS (A) after pulse. Inset: trace of ab- 
sorption as a function of time at 510 nm. 
4. DISCUSSION 
We have demonstrated that MMI, the active 
metabolite of the antithyroid drug methimazole, 
can scavenge OH * and Ii - protecting sensitive en- 
zymes against inactivation by these radicals. Pulse 
radiolysis facilitated the direct observations of the 
products of these reactions. Measurements of the 
absolute rate constants for the reaction of MM1 
with OH- and Ii- indicate that these reactions are 
likely to proceed very rapidly at intrathyroidal 
levels of MM1 achieved during treatment for 
hyperthyroidism [ 121. These findings therefore 
suggest that MM1 is capable of acting as a free 
radical scavenger in the thyroid. 
The products of the reaction of MM1 and OH * 
and Ii - are likely to include the drug radical 
cation: 
OH. + MM1 - OH- + MMI’+ 
and 12 * + MM1 - 21- + MMI’+ 
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This may be analogous to the reactions between 
free radicals and the phenothiazine drugs which 
share structural similarities with MMI. Pheno- 
thiazines act as free radical scavengers in vitro and 
in vivo 1131 and react with OH * and halogen 
radicals to give radical cations which have absorp- 
tion maxima at 510 nm [14]. 
Methimazole has been shown to protect against 
damage by OH * in s~pathetic nerve terminals in 
vitro, presumably by radical scavenging f151. Re- 
cent data demonstrating that hydroxyl radical 
scavengers inhibit natural killer cell cytotoxicity in 
vitro have indicated that compounds with this pro- 
perty may be capable of altering the functions of 
cells involved in the ~mune response [16]. The 
finding that MM1 inhibits luminol-de~ndent 
chemiluminesence in antigen-primed monocytes 
has led to the supposition that this drug acts upon 
these cells by direct inhibition of peroxidase en- 
zymes and/or scavenging of oxygen radicals [7]. 
Our data demonstrate that scavenging of OH* by 
concentrations of MM1 used in that study does in- 
deed take place. 
Iodine free radicals may be formed during the 
iodination of tyrosine residues by the thyroid 
peroxidase system [4]. The interaction of MM1 
with the com~nents of thyroid hormone biosyn- 
thesis is complex and the finding that MM1 readily 
scavenges radicals may only be a fundamental 
mechanism involved in the interactions between 
iodine, thyroid peroxidase and MMI. It is worthy 
of note, however, that recent evidence suggests 
that the extent of inhibition of thyroid hormone 
biosynthesis by MM1 is dependent on the ratio of 
drug to iodide available to the thyroid peroxidase 
system [17]. 
The data presented here expose a fundamental 
property of MMI which may provide a biochemic- 
al basis for the actions of this drug on the thyroid 
follicular cells and on the antigen presenting cells 
during treatment for Graves’ hyperthyroidism. 
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